Paper42931991PubMed
At the Crossroads of Synapses and Signaling: The Role of LRRK2 in Neuronal Communication.
Di Iacovo A and 5 others. Cell Mol Neurobiol, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. At the Crossroads of Synapses and Signaling: The Role of LRRK2 in Neuronal Communication. Papers, record 42931991. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42931991
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- At the Crossroads of Synapses and Signaling: The Role of LRRK2 in Neuronal Communication.
- Journal
- Cell Mol Neurobiol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-29
Source PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Major topic |
| Signal Transduction | Major topic |
| Synapses | Major topic |
| Neurons | Major topic |
| Cell Communication | Major topic |
| Animals | |
| Humans | |
| Synaptic Transmission | |
| Protein Transport |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,663,853 | PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins. | Elife | 2019 | https://conductscience.org/library/papers/31663853 | PubMed |
| 2 | 30,647,193 | Rab29 activation of the Parkinson's disease-associated LRRK2 kinase. | EMBO J | 2019 | https://conductscience.org/library/papers/30647193 | PubMed |
| 3 | 32,873,436 | Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease. | Neurobiol Aging | 2021 | https://conductscience.org/library/papers/32873436 | PubMed |
| 4 | 24,874,075 | Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24874075 | PubMed |
| 5 | 34,322,000 | A Computational Study of Astrocytic GABA Release at the Glutamatergic Synapse: EAAT-2 and GAT-3 Coupled Dynamics. | Front Cell Neurosci | 2021 | https://conductscience.org/library/papers/34322000 | PubMed |
| 6 | 32,256,311 | The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System. | Front Neurosci | 2020 | https://conductscience.org/library/papers/32256311 | PubMed |
| 7 | 32,523,507 | "LRRK2: Autophagy and Lysosomal Activity". | Front Neurosci | 2020 | https://conductscience.org/library/papers/32523507 | PubMed |
| 8 | 38,968,112 | Parkinson's-linked LRRK2-G2019S derails AMPAR trafficking, mobility, and composition in striatum with cell-type and subunit specificity. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38968112 | PubMed |
| 9 | 33,554,649 | Influence of glutamate and GABA transport on brain excitatory/inhibitory balance. | Exp Biol Med (Maywood) | 2021 | https://conductscience.org/library/papers/33554649 | PubMed |
| 10 | 20,842,175 | Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. | Nat Rev Neurosci | 2010 | https://conductscience.org/library/papers/20842175 | PubMed |
| 11 | 38,313,055 | Lysosomal stress drives the release of pathogenic α-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway. | iScience | 2024 | https://conductscience.org/library/papers/38313055 | PubMed |
| 12 | 33,674,612 | Dynamic control of the dopamine transporter in neurotransmission and homeostasis. | NPJ Parkinsons Dis | 2021 | https://conductscience.org/library/papers/33674612 | PubMed |
| 13 | 30,209,220 | LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30209220 | PubMed |
| 14 | 30,837,320 | LRRK2 links genetic and sporadic Parkinson's disease. | Biochem Soc Trans | 2019 | https://conductscience.org/library/papers/30837320 | PubMed |
| 15 | 39,655,696 | The kinase LRRK2 is required for the physiological function and expression of the glial glutamate transporter EAAT2 (SLC1A2). | J Neurochem | 2025 | https://conductscience.org/library/papers/39655696 | PubMed |
| 16 | 32,997,602 | Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases. | Annu Rev Pharmacol Toxicol | 2021 | https://conductscience.org/library/papers/32997602 | PubMed |
| 17 | 26,365,310 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. | Nat Commun | 2015 | https://conductscience.org/library/papers/26365310 | PubMed |
| 18 | 26,269,629 | The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus. | J Neurosci | 2015 | https://conductscience.org/library/papers/26269629 | PubMed |
| 19 | 22,420,899 | Astrocytes convert network excitation to tonic inhibition of neurons. | BMC Biol | 2012 | https://conductscience.org/library/papers/22420899 | PubMed |
| 20 | 23,395,371 | RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. | Neuron | 2013 | https://conductscience.org/library/papers/23395371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42931991
GET https://conductscience.org/api/papers/v1/42931991/references?page=2